Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02477183

Ligand	Ligand name	Chain	PDB	Tanimoto
HC2	20-HYDROXYCHOLESTEROL	A	1ZHW	0.71
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPG	0.76
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPJ	0.76
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPF	0.76
WIN	methyl (5beta,7alpha,9beta,10alpha,11alpha,12alpha,13beta,15alpha)-15-{[(2E)-3,4-dimethylpent-2-enoyl]oxy}-3,11,12-trihydroxy-2,16-dioxo-13,20-epoxypicras-3-en-21-oate	0,1,2,3,9,A,B,C,F,H,J,K,L,M,N,O,Q,R,S,T,U,Y,Z	3G71	0.7
0AS	asiatic acid	A	2QN1	0.73
HC3	25-HYDROXYCHOLESTEROL	A	1ZHX	0.71
SIH	PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE	H	1DBM	0.76
DGX	DIGOXIN	B,D	1IGJ	0.73
OBN	OUABAIN	H,L	1IBG	0.76
CBO	CARBENOXOLONE	A,B,C,D	1HDC	0.7
CBO	CARBENOXOLONE	A,B,C,D	2BEL	0.7
1CA	DESOXYCORTICOSTERONE	A,B	1Y9R	0.73
1CA	DESOXYCORTICOSTERONE	A,B,C	2ABI	0.73
1CA	DESOXYCORTICOSTERONE	A	2Q3Y	0.73
1CA	DESOXYCORTICOSTERONE	A	2AA7	0.73
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A,B	2VDY	0.76
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A	2V95	0.76
C3O	2ALPHA-PROPOXY-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HAS	0.71
TH2	TESTOSTERONE HEMISUCCINATE	A,B	2CBT	0.77
TH2	TESTOSTERONE HEMISUCCINATE	A,B,C,D,E,F	2CBQ	0.77
TH2	TESTOSTERONE HEMISUCCINATE	A	2CBO	0.77
SOD		A	2E1R	0.71
COV	(1S,3R,5Z,7E,14beta,17alpha)-17-[(2S,4S)-4-(2-hydroxy-2-methylpropyl)-2-methyltetrahydrofuran-2-yl]-9,10-secoandrosta-5,7,10-triene-1,3-diol	A	3CS4	0.74
FUA	FUSIDIC ACID	A	1QCA	0.73
FUA	FUSIDIC ACID	A,B,C,D,E,F,G,H,I,J,K,L	1Q23	0.73
FUA	FUSIDIC ACID	A,B	2VUF	0.73
20E	(2beta,3beta,5beta,22R)-2,3,14,20,22,25-hexahydroxycholest-7-en-6-one	A,D	2R40	0.78
GR3	3-ACETOXY-17-(1-FORMYL-5-METHYL-3-OXO-HEX-4-ENYL)-16-HYDROXY-4,10,13,14-TETRAMETHYL-2,3,4,5,6,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-4-CARBOXYLIC ACID	B,D	1AWH	0.74
DL7	(5beta,14beta,17alpha,25R)-3-oxocholest-7-en-26-oic acid	A	3GYU	0.73
DEX	DEXAMETHASONE	A,D	1M2Z	0.74
DEX	DEXAMETHASONE	A,B,C,D	1P93	0.74
CBW	(3BETA,5BETA,14BETA)-3-HYDROXY-11-OXOOLEAN-12-EN-29-OIC ACID	A	2W4Q	0.7
C0R	CORTICOSTERONE	A	2A3I	0.74
C0R	CORTICOSTERONE	A,B	1Y5R	0.74
MOU		A,B	2NPF	0.76
OCC	2ALPHA-(3-HYDROXYPROPOXY)-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HAR	0.71
CLL	CHOLESTERYL LINOLEATE	A,B	1CLE	0.73
TES	TESTOSTERONE	A	1JTV	0.76
TES	TESTOSTERONE	A	2Q7L	0.76
TES	TESTOSTERONE	A	2Q7I	0.76
TES	TESTOSTERONE	A,B	1J96	0.76
TES	TESTOSTERONE	A	2Q7K	0.76
TES	TESTOSTERONE	A,B	1Q13	0.76
TES	TESTOSTERONE	H	1I9J	0.76
TES	TESTOSTERONE	A,B	1AFS	0.76
TES	TESTOSTERONE	H	1VPO	0.76
TES	TESTOSTERONE	A	2Q7J	0.76
TES	TESTOSTERONE	A,B	3BUR	0.76
TES	TESTOSTERONE	A	2AM9	0.76
GR4		H,I	1AWF	0.79
ZBA	12,13-Epoxytrichothec-9-ene-3,4,8,15-tetrol-4,15-diacetate-8-isovalerate	A	2RKV	0.72
ZBA	12,13-Epoxytrichothec-9-ene-3,4,8,15-tetrol-4,15-diacetate-8-isovalerate	A,B,C,D	2ZBA	0.72
PLO	(3BETA)-3-HYDROXYPREGN-5-EN-20-ONE	A	1Q20	0.78
DTX	DIGITOXIGENIN	A	1LNM	0.72
KH1	5-(2-{1-[1-(4-ETHYL-4-HYDROXY-HEXYLOXY)-ETHYL]-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE}-ETHYLIDENE)-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1IE8	0.71
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	A,D	1R1K	0.78
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	E,U	1Z5X	0.78
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	E,F,G,H	2NXX	0.78
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EAU	0.72
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EB3	0.72
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EB4	0.72
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A,B	2AAX	0.72
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	1H61	0.72
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A,B	3CMF	0.72
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	2Q1V	0.72
AS4	ALDOSTERONE	A	2AA2	0.71
AS4	ALDOSTERONE	A	2Q1H	0.71
ZK5	9ALPHA-FLUOROCORTISOL	A	1GS4	0.75
CO1	17-[3-(3,3-DIMETHYL-OXIRANYL)-1-METHYL-PROPYL]-10,13-DIMETHYL-2,3,4,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-3-OL	A,B	1P8D	0.75
DL4	(14beta,17alpha,25R)-3-oxocholest-4-en-26-oic acid	A	3GYT	0.71
SXN	Salinixanthin	A,B	3DDL	0.72
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A,B	1E3R	0.77
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	3DHE	0.77
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1J99	0.77
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1COY	0.77
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1Q22	0.77
GMM	GLUCOSE MONOMYCOLATE	A	1UQS	0.7
DOG	DIGOXIGENIN	A	1LKE	0.73
NTH	SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER	A,B	1BUQ	0.76
0CO	(1S,3R,5Z,7E,14beta,17alpha,23R)-23-(2-hydroxy-2-methylpropyl)-20,24-epoxy-9,10-secochola-5,7,10-triene-1,3-diol	A	3CS6	0.74
2OB	CHOLESTERYL OLEATE	A	2OBD	0.73